Literature DB >> 9889256

Expression of anchorin CII (cartilage annexin V) in human young, normal adult, and osteoarthritic cartilage.

J Mollenhauer1, M T Mok, K B King, M Gupta, S Chubinskaya, H Koepp, A A Cole.   

Abstract

In its tissue-specific function as a collagen receptor of chondrocytes, cartilage annexin V (anchorin CII) occupies a key position in the organization of the cell-extracellular matrix (ECM) junction for the tissue. The general role of annexin V (Anx V) in other tissues suggests involvement in cellular secretory processes and in regulation of apoptosis. Immunohistochemical analysis of Anx V in growth plate cartilage, confirmed by in situ hybridization, suggests that Anx V is prominently expressed and forms a major constituent of growth plate chondrocytes. Anx V epitopes are also located in the pericellular matrix of hypertrophic cartilage. In adult articular cartilage the expression is downregulated, with the highest levels of immunostaining found in the upper third of the articular cartilage layers and almost no antigen found in the deep layers. Osteoarthritic (OA) cartilage is characterized by a significant upregulation of message and protein throughout the entire depth of the tissue, an accumulation of cytoplasmic annexin V epitopes, and a release of epitopes into the pericellular and interterritorial matrix, in part co-localized with granular structures. Therefore, Anx V expression and tissue distribution may serve as a histological marker for metabolic alterations and for changes in the cellular phenotype associated with OA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9889256     DOI: 10.1177/002215549904700209

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  9 in total

1.  Collagen/annexin V interactions regulate chondrocyte mineralization.

Authors:  Hyon Jong Kim; Thorsten Kirsch
Journal:  J Biol Chem       Date:  2008-02-14       Impact factor: 5.157

2.  Expression of early and late differentiation markers (proliferating cell nuclear antigen, syndecan-3, annexin VI, and alkaline phosphatase) by human osteoarthritic chondrocytes.

Authors:  D Pfander; B Swoboda; T Kirsch
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

Review 3.  Articular cartilage calcification and matrix vesicles.

Authors:  David S Howell
Journal:  Curr Rheumatol Rep       Date:  2002-06       Impact factor: 4.592

4.  Apoptosis in normal and osteoarthritic human articular cartilage.

Authors:  F Héraud; A Héraud; M F Harmand
Journal:  Ann Rheum Dis       Date:  2000-12       Impact factor: 19.103

5.  Short-term exposure of cartilage to blood results in chondrocyte apoptosis.

Authors:  Michel Hooiveld; Goris Roosendaal; Marion Wenting; Marijke van den Berg; Johannes Bijlsma; Floris Lafeber
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

6.  Perturbation of adhesion molecule-mediated chondrocyte-matrix interactions by 4-hydroxynonenal binding: implication in osteoarthritis pathogenesis.

Authors:  Rana El-Bikai; Mélanie Welman; Yoran Margaron; Jean-François Côté; Luke Macqueen; Michael D Buschmann; Hassan Fahmi; Qin Shi; Karim Maghni; Julio C Fernandes; Mohamed Benderdour
Journal:  Arthritis Res Ther       Date:  2010-10-26       Impact factor: 5.156

7.  Galectin-3 surface expression on human adult chondrocytes: a potential substrate for collagenase-3.

Authors:  M Guévremont; J Martel-Pelletier; C Boileau; F-T Liu; M Richard; J-C Fernandes; J-P Pelletier; P Reboul
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

8.  Sodium Thiosulfate Prevents Chondrocyte Mineralization and Reduces the Severity of Murine Osteoarthritis.

Authors:  Sonia Nasi; Hang-Korng Ea; Frédéric Lioté; Alexander So; Nathalie Busso
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

9.  Time-dependent proteomic and genomic alterations in Toll-like receptor-4-activated human chondrocytes: increased expression of lamin A/C and annexins.

Authors:  Seung Hee Ha; Hyoung Kyu Kim; Nguyen Thi Tuyet Anh; Nari Kim; Kyung Soo Ko; Byoung Doo Rhee; Jin Han
Journal:  Korean J Physiol Pharmacol       Date:  2017-08-22       Impact factor: 2.016

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.